Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

4DMedical (ASX:4DX) Slips About 3.8% Intraday as Investors Assess Recent Rally

Shares of 4DMedical Limited (ASX:4DX) eased about 3.8% during intraday trading on 21 July 2026 following a period of significant share price gains. No fresh company-specific announcement was identified to explain the move, with the decline appearing to reflect broader market activity after the …

Aditi Sarkar | 21 July 2026

Avita Medical (ASX:AVH) Gains 4.00% as Commercial Expansion of Regenerative Medicine Platform Continues

Avita Medical, Inc. (ASX:AVH) ended the latest trading session with a 4.00% gain, closing at AUD 4.68. Trading turnover reached approximately AUD 2.03 million, while the company maintained a market capitalisation of around AUD 618.64 million. Despite fluctuations over the past year, the latest …

Aditi Sarkar | 21 July 2026

INOVIQ (ASX:IIQ) Gains 5.00% as Diagnostics and Exosome Research Programmes Continue to Advance

INOVIQ Ltd (ASX:IIQ) ended the latest trading session with a 5.00% gain, closing at AUD 0.21. Trading turnover reached AUD 4,874, while the healthcare company maintained a market capitalisation of approximately AUD 29.56 million. Although the stock has declined 43.24% over the past year, …

Aditi Sarkar | 21 July 2026

Clinuvel Pharmaceuticals (ASX:CUV) Lands on Nasdaq—Could Its New US Listing Transform Global Investor Interest?

Clinuvel Pharmaceuticals (ASX:CUV) upgraded its US depositary program from a Level I over-the-counter ADR to a Level II American Depositary Share listing on the Nasdaq Global Select Market, trading as CUVL from Monday 20 July 2026 (New York time). It is a listing, not …

Aditi Sarkar | 21 July 2026

Telix Pharmaceuticals (ASX:TLX) Targets More Than US$1 Billion in Revenue and Other Income After Quarterly Revenue Jumps 21%

Telix Pharmaceuticals (ASX:TLX) said second-quarter revenue rose 21 per cent to US$247 million (A$353.2 million), led by a 30 per cent lift in precision-medicine sales to US$202 million. It reaffirmed FY2026 revenue guidance of US$950 million to US$970 million and is tracking toward the …

Aditi Sarkar | 21 July 2026

Little Green Pharma (ASX:LGP) Climbs 4.55% as Medicinal Cannabis Business Expands Global Reach

Little Green Pharma Ltd (ASX:LGP) finished the latest trading session with a 4.55% gain, closing at AUD 0.115. Trading turnover reached AUD 57,328, while the company maintained a market capitalisation of approximately AUD 28.89 million. Although the stock has declined 22.03% over the past …

Aditi Sarkar | 21 July 2026

VALRX (ASX:VAL) Adds 4.76% as Biotechnology Development Programmes Continue to Advance

VALRX Ltd (ASX:VAL) ended the latest trading session with a 4.76% increase, closing at AUD 0.022. Trading turnover totalled AUD 6,528, while the healthcare company maintained a market capitalisation of approximately AUD 12.53 million. Although the shares have declined 18.52% over the past 12 …

Aditi Sarkar | 21 July 2026

Atomo Diagnostics (ASX:AT1) Edges Up 6.25% as Point-of-Care Testing Strategy Progresses

Atomo Diagnostics Ltd (ASX:AT1) finished the latest trading session with a 6.25% gain, closing at AUD 0.017. Trading turnover was modest at AUD 561, while the healthcare technology company carried a market capitalisation of approximately AUD 15.34 million. Although the shares remain 15.00% below …

Aditi Sarkar | 21 July 2026

Ryman Healthcare (ASX:RYM) Stages a 7.94% Recovery as Operational Momentum Draws Market Focus

Ryman Healthcare Ltd (ASX:RYM) returned to positive territory after its shares rose 7.94% to close at AUD 1.84. The session recorded turnover of AUD 1,475, while the retirement village operator carried a market capitalisation of approximately AUD 1.86 billion. Although the stock remains 19.52% …

Aditi Sarkar | 21 July 2026

Cyclopharm (ASX:CYC) Adds 7.14% as Commercial Expansion Strategy Remains on Investors' Radar

Cyclopharm Ltd (ASX:CYC) ended the latest trading session 7.14% higher at AUD 0.60. Trading turnover reached AUD 60,002, while the healthcare company carried a market capitalisation of approximately AUD 75.44 million. Although the shares remain 44.44% lower over the past 12 months, the latest …

Aditi Sarkar | 21 July 2026
Support

Hi! How can we help you today?

Loading…